Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 61.47

-3.9%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

OldAIMGuy

Sun Tzu

To: software salesperson who wrote (52118)	11/5/2024 11:49:40 AM
From: software salesperson	2 Recommendations of 52153

nature.com the effects of GLP-1 agonists across the economy. one nugget: And some lawmakers, including in the United States, are beginning to push back on the high costs, particularly after an analysis found that Novo Nordisk could sell Ozempic for $5 per month and still make a profit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next